Haploidentical Vs. Matched Unrelated Donor Transplants Using Post-Transplant Cyclophosphamide for Lymphoma: A Joint CIBMTR/EBMT Study
Alberto Mussetti(Duran i Reynals Hospital), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Steven G. E. Marsh(CRUK Lung Cancer Centre of Excellence), Luca Castagna(Humanitas University), Didier Blaise(Institut Paoli-Calmettes), Stephanie J. Lee(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Yung‐Tsi Bolon(National Marrow Donor Program), Sophie Paczesny(MUSC Hollings Cancer Center), Hervé Finel, Stephen R. Spellman(National Marrow Donor Program), Abraham S. Kanate(HonorHealth), Shahinaz M. Gadalla(Division of Cancer Epidemiology and Genetics), Meilun He(National Marrow Donor Program), Peter Dreger(Heidelberg University), Tao Wang(Medical College of Wisconsin), Ariane Boumendil(Inserm), Bertram Glaß(Helios Hospital Berlin-Buch), Mehdi Hamadani(Medical College of Wisconsin)
Cited by 3
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
|Journal of Clinical Oncology|2006|2k
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k